Triton CG ‐110 as an alternative for cell lysis in manufacturing of adeno‐associated virus ‐based gene therapy
Year: 2025
Type: article
Source: Biotechnology Progress
DOI: 10.1002/btpr.70025
Authors: Yixuan Ming, Tianyi Zhou, Bin Lu, Yemaiza Ojeda‐Lassalle, Pasquale Valerio, Lu Wang, Mi Jin
Institution: Spark Therapeutics (United States)
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4408885283
